Loading clinical trials...

Direct Anterior Approach for Femoral Neck Fractures | Clinical Trials | Clareo Health

COMPLETEDNA

Direct Anterior Approach for Femoral Neck Fractures

A Randomized Controlled Trial Comparing Direct Anterior Approach to Direct Lateral Approach in Patients Receiving a Total Hip Arthroplasty for Femoral Neck Fracture - a 1 Year Follow-up Study

NCT03695497•Helse Møre og Romsdal HF

View on ClinicalTrials.gov

Summary

The primary objective is to examine if in patients with a dislocated femoral neck fracture who receive a total hip arthroplasty, direct anterior approach will give a better result in terms of mobilization, function and pain in the first weeks and months postoperatively, than direct lateral approach.

Detailed Description

first included patient 23th November 2018

Eligibility

Age

50 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Dislocated femoral neck fracture

Exclusion Criteria

•Infection around the hip (soft tissue or bone)
•Pathologic fracture
•Excessive alcohol or substance abuse that most likely will give reduced compliance
•Patients with any fractures of the long bones in the lower extremity, fracture of the spine, and/or intra-thoracic or intra-abdominal injury (i.e., multiple trauma). Because the outcomes and clinical course of patients with multiple trauma may be quite different from a non-trauma patient.
•Bedridden patients/non-walkers
•Patients with an underlying illness that doesn't have life expectancy beyond six months
•In case of severe cognitive impairment where the patients are not able to give their informed consent

Locations (1)

Kristiansund Hospital

Kristiansund, Norway

Key Dates

Start Date

October 1, 2018

Primary Completion Date

December 15, 2023

Completion Date

December 15, 2023

Last Updated

November 1, 2024

Enrollment

130

ACTUAL participants

Conditions

Femoral Neck Fractures

Interventions

Direct anterior approach

PROCEDURE

Direct Lateral Approach

PROCEDURE

Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty (PENG)

NCT06565910

Femoral Neck FracturesFemur Head Necrosis+1 more

View study

RECRUITINGNA

Sacral ESPB vs. PENG Block for Hip Hemiarthroplasty Analgesia

NCT07442721

Hip ArthroplastyHip Fracture Surgeries+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 1, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Direct Anterior Approach for Femoral Neck Fractures

Inclusion Criteria

Exclusion Criteria

Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty (PENG)

Sacral ESPB vs. PENG Block for Hip Hemiarthroplasty Analgesia

Evaluation of Fracture Migration After Internal Fixation of Femoral Neck Fractures in Younger Adults: A Clinical RCT Using RSA

Opioid-Free Pain Treatment in Trauma Patients

Prospective Validation Study of the CD8+TEMRA Cells As a Prognostic Biomarker of Healing Outcome After Fracture

G7 BiSpherical Acetabular Shell PMCF Study